Buchumschlag

Amylin analogues as a novel perspective in anti‐obesity therapy

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Thomas A. Lutz
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2026
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes
von: Andrea Baragetti, et al.
Veröffentlicht: (2026)

Immunotherapy in cancer: novel approaches and future perspectives
von: Barbara Stefanska, et al.
Veröffentlicht: (2025)

Therapeutic targeting of GSK‐3β activation by the tyrosine kinase RYK in pancreatic ductal adenocarcinoma with BJ‐2412, a novel sunitinib analogue
von: Kiran Yadav, et al.
Veröffentlicht: (2026)

Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent
von: Bing Shang, et al.
Veröffentlicht: (2024)

Integrating novel immunotherapeutic approaches in organ‐preserving therapies for bladder cancer
von: Éva Michaud, et al.
Veröffentlicht: (2024)

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients
von: Dávid Nagy, et al.
Veröffentlicht: (2025)

Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment
von: Shibeilei Lin, et al.
Veröffentlicht: (2025)

Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin‐based therapies
von: Ilaria Serra, et al.
Veröffentlicht: (2026)

QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age‐related macular degeneration
von: Samantha Arokiasamy, et al.
Veröffentlicht: (2024)

Development of new Kir2.1 channel openers from propafenone analogues
von: Encan Li, et al.
Veröffentlicht: (2024)

A novel synthesised STAT3 inhibitor exerts potent anti‐tumour activity by inducing lysosome‐dependent cell death
von: Marvin Xuejun Xu, et al.
Veröffentlicht: (2025)

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
von: Luca Botticelli, et al.
Veröffentlicht: (2025)

Cyclodextrin‐based delivery of Annexin A1 mimetic Ac2–26 enhances anti‐inflammatory effect and prevents dengue‐induced lethality combined with antiviral therapy
von: Jenniffer Ramos Martins, et al.
Veröffentlicht: (2026)

Efficacy in diet‐induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837
von: Martin E. Cooper, et al.
Veröffentlicht: (2024)

Early clinical pharmacology evaluation of the novel anti‐inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions
von: Dave Singh, et al.
Veröffentlicht: (2026)

Natural products and cancer: From drug discovery to prevention and therapy
von: Angelo A. Izzo, et al.
Veröffentlicht: (2025)

Psilocybin as a novel treatment for chronic pain
von: Tate Askey, et al.
Veröffentlicht: (2024)

Cytochrome P450 1A1 influences obesity‐induced pulmonary hypertension
von: Joshua P. Dignam, et al.
Veröffentlicht: (2025)

Diltiazem N‐oxide, a novel ischaemia‐activated prodrug, prevents ischaemia‐induced ventricular fibrillation without off‐target adverse effects
von: Louise M. Hesketh, et al.
Veröffentlicht: (2026)

Does dosing frequency of anti‐CD20 therapies blunt vaccine responses and increase COVID‐19 susceptibility in patients with multiple sclerosis?
von: Jagannadha Avasarala
Veröffentlicht: (2024)

Natural product pharmacology: the British Journal of Pharmacology perspective
von: Xin Wang, et al.
Veröffentlicht: (2024)

Pharmacological and molecular characterization of a chalcone analogue derived from a Senecio nutans metabolite: Modulation of Ca V 1.2 and K Ca 1.1 channels in hypertensive rats
von: Daniel Asunción‐Alvarez, et al.
Veröffentlicht: (2026)

Monocytic microRNAs—Novel targets in atherosclerosis therapy
von: Gerhild Euler, et al.
Veröffentlicht: (2024)

Ginsenoside Rh4 prevents endothelial dysfunction as a novel AMPK activator
von: Jiawei Zhang, et al.
Veröffentlicht: (2024)

SHR‐1703, a novel long‐acting anti‐interleukin‐5 monoclonal antibody, in asthma patients: A randomized, double‐blind, placebo‐controlled phase 1 study
von: Ling Yang, et al.
Veröffentlicht: (2026)

Inhibition of peripheral CB 1 receptors modulates food intake and metabolic efficiency in obesity independently of the gut–brain vagal axis
von: Oriane Onimus, et al.
Veröffentlicht: (2026)

Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice
von: Lu Bai, et al.
Veröffentlicht: (2024)

Cell‐based therapy for diabetic cardiovascular complications: Prospects and challenges
von: Jia‐Peng Li, et al.
Veröffentlicht: (2024)

Determination of the optimal obesity‐adjusted dosing weight for enoxaparin
von: Gregory W. Roberts, et al.
Veröffentlicht: (2024)

Systematic drug screening and target analysis identify digitoxin as a potential therapy for uveal melanoma
von: Huilin Liu, et al.
Veröffentlicht: (2024)

Compartmentalisation in cAMP signalling: A phase separation perspective
von: Milda Folkmanaite, et al.
Veröffentlicht: (2025)

High‐throughput screen identifies MAS9 as a novel inhibitor of the C‐type lectin receptor‐2 (CLEC‐2)–podoplanin interaction
von: Marcin A. Sowa, et al.
Veröffentlicht: (2025)

Preclinical and translational pharmacology of afucosylated anti‐CCR8 antibody for depletion of tumour‐infiltrating regulatory T cells
von: Gautham Gampa, et al.
Veröffentlicht: (2024)

Anti‐cathepsin D immunotherapy triggers both innate and adaptive anti‐tumour immunity in breast cancer
von: Timothée David, et al.
Veröffentlicht: (2024)

A novel role for microtubule affinity‐regulating kinases in neuropathic pain
von: Yao‐Qin Shi, et al.
Veröffentlicht: (2024)

Use of cimetidine to enhance systemic acyclovir concentrations in patients with ineffective suppressive therapy for recurring herpes simplex virus infections: A novel purpose for an old drug
von: Dominique G. Stuijt, et al.
Veröffentlicht: (2025)

Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy
von: Océane Pointeau, et al.
Veröffentlicht: (2025)

Schedule‐dependent neuroprotection by pioglitazone in a novel model of α‐synucleinopathy in rats: Integrated behavioural and histological outcomes
von: Alberto Santiago‐Balmaseda, et al.
Veröffentlicht: (2026)

Role of microtubule affinity‐regulating kinases in epilepsy: A novel therapeutic strategy
von: Min Xu, et al.
Veröffentlicht: (2026)

Endothelium‐ and epithelium‐derived novel endogenous catecholamines as modulators of the autonomic nervous system
von: Mariana G. de Oliveira, et al.
Veröffentlicht: (2026)